Back to Awarded Treatment Trials
Awarded Trial: 98-RC-325B-4
Grant ID
98-RC-325B-4
Illness
Bipolar Disorder
Primary Drug/Intervention
Risperidone
Primary Dosage
N/A
Secondary Drug Intervention
Olanzapine/Quetiapine
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Biederman
Sample Size
120
Duration of Study Period for Each Subject
8 weeks
Outcome Measurements
YMRS
Results
Children and adolescents, aged 7-18 received treatment with risperidone, olazapine or quetiapine for bipolar disoder. All three drugs were associated with a similar level of improvement. Olazapine was associated with a greater degree of weight gain.
Publication
N/A
Link
N/A
PI Name
Joseph Biederman
Degree
MD
Center
ADHD Program
Institution
Massachusetts General Hospital
Address
185 Alewife Brook Parkway, Suite 200
City or Town
Cambridge
State or Province
MA
Zip or Postal Code
2114
Country
USA
Email Address
biederman@helix.mgh.harvard.edu